522 related articles for article (PubMed ID: 16864779)
21. Immunoglobulin heavy chain variable gene usage and (super)-antigen drive in chronic lymphocytic leukemia.
Bühler A; Zenz T; Stilgenbauer S
Clin Cancer Res; 2010 Jan; 16(2):373-5. PubMed ID: 20068107
[TBL] [Abstract][Full Text] [Related]
22. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
[TBL] [Abstract][Full Text] [Related]
23. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens.
Chiorazzi N; Hatzi K; Albesiano E
Ann N Y Acad Sci; 2005 Dec; 1062():1-12. PubMed ID: 16461783
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia.
Mauerer K; Zahrieh D; Gorgun G; Li A; Zhou J; Ansén S; Rassenti LZ; Gribben JG
Br J Haematol; 2005 May; 129(4):499-510. PubMed ID: 15877732
[TBL] [Abstract][Full Text] [Related]
25. Analysis of VH gene expression in CD5+ and CD5- B-cell chronic lymphocytic leukemia.
Maloum K; Davi F; Magnac C; Pritsch O; McIntyre E; Valensi F; Binet JL; Merle-Béral H; Dighiero G
Blood; 1995 Nov; 86(10):3883-90. PubMed ID: 7579357
[TBL] [Abstract][Full Text] [Related]
26. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.
Pal Singh S; de Bruijn MJW; de Almeida MP; Meijers RWJ; Nitschke L; Langerak AW; Pillai SY; Stadhouders R; Hendriks RW
Front Immunol; 2018; 9():1996. PubMed ID: 30271400
[TBL] [Abstract][Full Text] [Related]
27. The B cell antigen receptor in atypical chronic lymphocytic leukemia with t(14;19)(q32;q13) demonstrates remarkable stereotypy.
Schweighofer CD; Huh YO; Luthra R; Sargent RL; Ketterling RP; Knudson RA; Barron LL; Medeiros LJ; Keating MJ; Abruzzo LV
Int J Cancer; 2011 Jun; 128(11):2759-64. PubMed ID: 20715110
[TBL] [Abstract][Full Text] [Related]
28. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.
Stamatopoulos K; Belessi C; Moreno C; Boudjograh M; Guida G; Smilevska T; Belhoul L; Stella S; Stavroyianni N; Crespo M; Hadzidimitriou A; Sutton L; Bosch F; Laoutaris N; Anagnostopoulos A; Montserrat E; Fassas A; Dighiero G; Caligaris-Cappio F; Merle-Béral H; Ghia P; Davi F
Blood; 2007 Jan; 109(1):259-70. PubMed ID: 16985177
[TBL] [Abstract][Full Text] [Related]
29. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
30. Structural aspects of human IgM antibodies expressed in chronic B lymphocytic leukemia.
Ramsland PA; Brock CR; Moses J; Robinson BG; Edmundson AB; Raison RL
Immunotechnology; 1999 Mar; 4(3-4):217-29. PubMed ID: 10231091
[TBL] [Abstract][Full Text] [Related]
31. Selection during development of VH11+ B cells: a model for natural autoantibody-producing CD5+ B cells.
Hardy RR; Wei CJ; Hayakawa K
Immunol Rev; 2004 Feb; 197():60-74. PubMed ID: 14962187
[TBL] [Abstract][Full Text] [Related]
32. Evidence for somatic selection of natural autoantibodies.
Martin T; Duffy SF; Carson DA; Kipps TJ
J Exp Med; 1992 Apr; 175(4):983-91. PubMed ID: 1552291
[TBL] [Abstract][Full Text] [Related]
33. Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling.
Chen SS; Batliwalla F; Holodick NE; Yan XJ; Yancopoulos S; Croce CM; Rothstein TL; Chiorazzi N
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):E1500-7. PubMed ID: 23550156
[TBL] [Abstract][Full Text] [Related]
34. CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation.
Efanov A; Zanesi N; Nazaryan N; Santanam U; Palamarchuk A; Croce CM; Pekarsky Y
Leukemia; 2010 May; 24(5):970-5. PubMed ID: 20357824
[TBL] [Abstract][Full Text] [Related]
35. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state.
Herling M; Patel KA; Khalili J; Schlette E; Kobayashi R; Medeiros LJ; Jones D
Leukemia; 2006 Feb; 20(2):280-5. PubMed ID: 16341048
[TBL] [Abstract][Full Text] [Related]
36. B cells generated by B-1 development can progress to chronic lymphocytic leukemia.
Hayakawa K; Formica AM; Colombo MJ; Ichikawa D; Shinton SA; Brill-Dashoff J; Hardy RR
Ann N Y Acad Sci; 2015 Dec; 1362():250-5. PubMed ID: 25907284
[TBL] [Abstract][Full Text] [Related]
37. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
[TBL] [Abstract][Full Text] [Related]
38. Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.
Kriangkum J; Motz SN; Mack T; Beiggi S; Baigorri E; Kuppusamy H; Belch AR; Johnston JB; Pilarski LM
PLoS One; 2015; 10(9):e0137232. PubMed ID: 26353109
[TBL] [Abstract][Full Text] [Related]
39. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.
Hervé M; Xu K; Ng YS; Wardemann H; Albesiano E; Messmer BT; Chiorazzi N; Meffre E
J Clin Invest; 2005 Jun; 115(6):1636-43. PubMed ID: 15902303
[TBL] [Abstract][Full Text] [Related]
40. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.
Belessi CJ; Davi FB; Stamatopoulos KE; Degano M; Andreou TM; Moreno C; Merle-Béral H; Crespo M; Laoutaris NP; Montserrat E; Caligaris-Cappio F; Anagnostopoulos AZ; Ghia P
Eur J Immunol; 2006 Jul; 36(7):1963-74. PubMed ID: 16783849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
